A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4
一种新型的靶向TM4SF4的治疗性抗体候选药物,通过阻断IGF1R和CD44信号通路并下调PD-L1和B7-H4,发挥抗肿瘤活性。
期刊:Theranostics
影响因子:12.4
doi:10.7150/thno.113347.
Rae-Kwon Kim,Chang-Kyu Heo,Mun Ju Choi,Yeon-Jee Kahm,Min Kyu Kim,Minyong Lee,Ji Yoon Lee,Hwangseo Park,Uhee Jung,Byung-Chul Shin,Bum-Jin Kim,Sung-Chul Kim,Eun-Wie Cho,Chun Jeih Ryu,In-Gyu Kim
信号转导
肿瘤
信号转导
PD-L1
CD4
CD44
IGF1